← FDA Drug Approvals (Drugs@FDA)
OLOPATADINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2017-12-05
Drug application
- FDA Application #
ANDA204723- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OLOPATADINE HYDROCHLORIDE
- Generic name
- Olopatadine Hydrochloride
- Active ingredients
- OLOPATADINE HYDROCHLORIDE
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Discontinued
- Sponsor
- SCIEGEN PHARMS
- First approval
- 2017-12-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown